Israel - English - Ministry of Health

novartis israel ltd - nilotinib as monohydrate - capsules - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Israel - English - Ministry of Health

novartis israel ltd - nilotinib as hydrochloride monohydrate - capsules - nilotinib as hydrochloride monohydrate 150 mg - nilotinib - nilotinib - treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - nilotinib hydrochloride monohydrate 220.6 mg eqv nilotinib anhydrous - capsule - 200mg - nilotinib hydrochloride monohydrate 220.6 mg eqv nilotinib anhydrous 200mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - nilotinib hcl monohydrate 165.45mg eqv nilotinib - capsule - 150mg - nilotinib hcl monohydrate 165.45mg eqv nilotinib 150mg

European Union - English - EMA (European Medicines Agency)

bayer ag - iloprost - hypertension, pulmonary - antithrombotic agents - treatment of patients with primary pulmonary hypertension, classified as new york heart association functional class iii, to improve exercise capacity and symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - aspirin,dipyridamole -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; colloidal anhydrous silica; hypromellose; macrogol 3350; titanium dioxide; purified talc; polyvinyl alcohol - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally, indapamide is used as the initial agent in multiple drug regimes.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: titanium dioxide; macrogol 6000; hypromellose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; glycerol; povidone - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally, ardix indapamide sr is used as the initial agent in multiple drug regimes.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: magnesium stearate; povidone; hypromellose; titanium dioxide; glycerol; macrogol 6000; colloidal anhydrous silica; lactose monohydrate - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally,tenaxil sr is used as the initial agent in multiple drug regimes.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - indapamide hemihydrate,perindopril erbumine -